FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 227 filers reported holding FATE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $164 | +811.1% | 77,199 | +1962.5% | 0.01% | +600.0% |
| Q2 2023 | $18 | -14.3% | 3,743 | -0.6% | 0.00% | 0.0% |
| Q1 2023 | $21 | -44.7% | 3,764 | -0.3% | 0.00% | -50.0% |
| Q4 2022 | $38 | -100.0% | 3,777 | -16.8% | 0.00% | -50.0% |
| Q3 2022 | $102,000 | -28.2% | 4,542 | -20.8% | 0.00% | 0.0% |
| Q2 2022 | $142,000 | -36.0% | 5,732 | +0.2% | 0.00% | -20.0% |
| Q1 2022 | $222,000 | -42.2% | 5,723 | -12.9% | 0.01% | -37.5% |
| Q4 2021 | $384,000 | -0.8% | 6,571 | +0.6% | 0.01% | -11.1% |
| Q3 2021 | $387,000 | -34.6% | 6,535 | -4.2% | 0.01% | -18.2% |
| Q2 2021 | $592,000 | – | 6,825 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $46,987,000 | 60.92% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $278,604,000 | 36.08% |
| Darwin Global Management, Ltd. | 1,370,133 | $112,967,000 | 22.12% |
| Redmile Group, LLC | 12,957,222 | $1,068,323,000 | 15.05% |
| Copernicus Capital Management, LLC | 8,000 | $660,000 | 10.66% |
| Casdin Capital, LLC | 3,400,000 | $280,330,000 | 8.35% |
| Grosvenor Holdings, L.L.C. | 1,123,576 | $92,639,000 | 6.81% |
| DAFNA Capital Management LLC | 314,360 | $25,919,000 | 6.15% |
| Ally Bridge Group (NY) LLC | 270,000 | $22,262,000 | 4.27% |
| Ghost Tree Capital, LLC | 185,000 | $15,253,000 | 3.58% |